Management of dyslipidemia in HIV-infected patients-Reference-Cited by-同舟云学术

Management of dyslipidemia in HIV-infected patients

Published:2011-08-01 Issue:4 Volume:6 Page:447-462
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Sugden Mary¹,Holness Mark¹

Affiliation:

1. University of London, Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Barts and London School of Medicine and Dentistry, Queen Mary, 4 Newark Street, Whitechapel, E1 2AT, London, UK, Tel.: ; Fax.: ,

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.11.25

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose quercetin at 25 mg/kg ameliorates dolutegravir-lamivudine-tenofovirdisoproxilfumarate-inducedcardio-hepato-renal toxicities in Wistar rats;Clinical Phytoscience;2024-08-02

2. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials;The Lancet HIV;2024-02

3. Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: An analysis of HIV and malaria patients in Ghana;PLOS ONE;2023-05-03

4. Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals;Vaccines;2022-12-30

5. Subclinical Atherosclerosis is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in HIV Treated Individuals;2022-08-26